Monday, November 26, 2018

Zimbabwe's Robert Mugabe unable to walk, seeking treatment in Singapore

Zimbabwe's Robert Mugabe unable to walk, seeking treatment in SingaporeFormer Zimbabwean leader Robert Mugabe has been receiving medical treatment in Singapore for the last two months and is no longer able to walk, though he should return home next week, President Emmerson Mnangagwa said on Saturday. Mr Mugabe, 94, who ruled the southern African nation for nearly four decades since independence from Britain in 1980, was forced to resign in November 2017 after an army coup. Mr Mnangagwa told ruling ZANU-PF supporters at a rally in Murombedzi, Mr Mugabe’s village some 100 km (60 miles) west of the capital Harare, his predecessor had been due to return on October 15 but that his poor health had delayed the journey. He did not say what treatment Mr Mugabe had been undergoing. “We have just received a message that he is better now and will return on November 30. "He can no longer walk but we will continue taking care of him,” Mr Mnangagwa said, referring to Mr Mugabe by his totem name Gushungo. Zimbabwe's President Emmerson Mnangagwa delivers a speech during a "Thank You" rally on November 24, 2018 Credit:  JEKESAI NJIKIZANA/AFP During his later years in power, Mr Mugabe made several medical trips to Singapore. Officials often said he was being treated for a cataract,denying frequent reports by private local media that he had prostate cancer. Mr Mnangagwa, who won a disputed July 30 presidential vote, repeated the army’s previous justification for last year’s coup, saying his former mentor Mr Mugabe had been surrounded by criminals. When the army rolled its tanks into Harare, military leaders said they were targeting “criminals around the president.” A bitter Mr Mugabe said later, however, that the army’s action had forced him to resign.




from Yahoo News - Latest News & Headlines https://ift.tt/2FF3u9b

No comments:

Post a Comment

Drug combination prompts immune response in some resistant pancreatic cancers

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one...